Your browser doesn't support javascript.
Unaltered T cell responses to common antigens in individuals with Parkinson's disease.
Williams, Gregory P; Muskat, Kaylin; Frazier, April; Xu, Yaqian; Mateus, José; Grifoni, Alba; da Silva Antunes, Ricardo; Weiskopf, Daniela; Amara, Amy W; Standaert, David G; Goldman, Jennifer G; Litvan, Irene; Alcalay, Roy N; Sulzer, David; Lindestam Arlehamn, Cecilia S; Sette, Alessandro.
  • Williams GP; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
  • Muskat K; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Frazier A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
  • Xu Y; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Mateus J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • da Silva Antunes R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Amara AW; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Standaert DG; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Goldman JG; Shirley Ryan AbilityLab, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Litvan I; Department of Neuroscience, University of California San Diego, La Jolla, CA 92093, USA.
  • Alcalay RN; Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
  • Sulzer D; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, NY 10032, USA; Departments of Psychiatry and Pharmacology, Columbia University; New Yo
  • Lindestam Arlehamn CS; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA. Electronic address: cecilia@lji.org.
  • Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA. Electr
J Neurol Sci ; 444: 120510, 2023 01 15.
Article in English | MEDLINE | ID: covidwho-2122629
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Parkinson's disease (PD) is associated with a heightened inflammatory state, including activated T cells. However, it is unclear whether these PD T cell responses are antigen specific or more indicative of generalized hyperresponsiveness. Our objective was to measure and compare antigen-specific T cell responses directed towards antigens derived from commonly encountered human pathogens/vaccines in patients with PD and age-matched healthy controls (HC).

METHODS:

Peripheral blood mononuclear cells (PBMCs) from 20 PD patients and 19 age-matched HCs were screened. Antigen specific T cell responses were measured by flow cytometry using a combination of the activation induced marker (AIM) assay and intracellular cytokine staining.

RESULTS:

Here we show that both PD patients and HCs show similar T cell activation levels to several antigens derived from commonly encountered human pathogens/vaccines in the general population. Similarly, we also observed no difference between HC and PD in the levels of CD4 and CD8 T cell derived cytokines produced in response to any of the common antigens tested. These antigens encompassed both viral (coronavirus, rhinovirus, respiratory syncytial virus, influenza, cytomegalovirus) and bacterial (pertussis, tetanus) targets.

CONCLUSIONS:

These results suggest the T cell dysfunction observed in PD may not extend itself to abnormal responses to commonly encountered or vaccine-target antigens. Our study supports the notion that the targets of inflammatory T cell responses in PD may be more directed towards autoantigens like α-synuclein (α-syn) rather than common foreign antigens.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Vaccines Topics: Vaccines Limits: Humans Language: English Journal: J Neurol Sci Year: 2023 Document Type: Article Affiliation country: J.jns.2022.120510

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Vaccines Topics: Vaccines Limits: Humans Language: English Journal: J Neurol Sci Year: 2023 Document Type: Article Affiliation country: J.jns.2022.120510